ASCI banned 87 ads including Ranbaxy, Dr Batra, P&G, Dabur, Emami and Cadbury in December
March 20, 2014
Health and personal care category continues to lead with the highest number of complaints received by ASCI during December 2013. However, throughout the year 40% of complaints came from education sector
Moneylife Digital Team
The Consumer Complaints Council (CCC) under the Advertising Standards Council of India (ASCI) has banned as many as 87 advertisements out of 108 complaints it received across segments during December 2013.